CRISPR-Cas9 Gene Therapy Cure for Sickle Cell Disease
A comprehensive look at the clinical validation of exagamglogene autotemcel, the first CRISPR-based gene editing therapy approved for sickle cell disease.
A comprehensive look at the clinical validation of exagamglogene autotemcel, the first CRISPR-based gene editing therapy approved for sickle cell disease.